<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Dabigatran; Pradaxa; Dabigatran" /><meta name="IX" content="Pradaxa; Dabigatran" /><meta name="IXM" content="Dabigatran" /><title>DABIGATRAN ETEXILATE: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP1505-dabigatran-etexilate.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP1505-dabigatran-etexilate.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP1505-dabigatran-etexilate.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP747-cardiovascular-system.htm">2 Cardiovascular system</a> &gt; <a href="PHP1438-anticoagulants-and-protamine.htm">2.8 Anticoagulants and protamine</a> &gt; <a href="PHP1484-oral-anticoagulants.htm">2.8.2 Oral anticoagulants</a> &gt; <a href="PHP1503-dabigatran-etexilate.htm">Dabigatran etexilate</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP1503-dabigatran-etexilate.htm" title="Previous: Dabigatran etexilate">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP1506-pradaxa.htm#PHP1506-pradaxa" title="Next: Pradaxa®">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a311009.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dabigatran Etexilate Mesylate</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Blood Formation, Coagulation, and Thrombosis 20:00 &gt; Antithrombotic Agents 20:12 &gt; Anticoagulants 20:12.04 &gt; Direct Thrombin Inhibitors 20:12.04.12</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/20786-b.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Dabigatran</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: D &gt; Interactions of Dabigatran</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP1503-dabigatran-etexilate.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dabigatran etexilate</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.2 Oral anticoagulants</p></div></li><li><a href="PHP1506-pradaxa.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pradaxa®</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 2 Cardiovascular system &gt; 2.8 Anticoagulants and protamine &gt; 2.8.2 Oral anticoagulants &gt; Dabigatran etexilate &gt; DABIGATRAN ETEXILATE</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/ms-20786-b.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dabigatran</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Cardiovascular Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/02797.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dabigatran</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; D &gt; DA</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E22E3E0R0D800.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Dabigatran</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; D</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>DABIGATRAN ETEXILATE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int1120-dabigatran-etexilate.htm">Dabigatran Etexilate</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">see <a title="BNF:monograph-family: Dabigatran etexilate" href="PHP1503-dabigatran-etexilate.htm">notes above</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see <a title="monograph-family: Dabigatran etexilate" href="PHP1503-dabigatran-etexilate.htm">notes above</a>; also elderly; body-weight less than 50 kg; recent surgery; anaesthesia with postoperative indwelling epidural catheter (risk of paralysis—give initial dose at least 2 hours after catheter removal and monitor neurological signs); bacterial endocarditis (increased risk of bleeding); bleeding disorders; active gastro-intestinal ulceration; assess renal function before treatment in all patients and at least annually in elderly and patients with renal impairment; concomitant use of drugs that increase risk of bleeding; <strong>interactions</strong>: Appendix 1 (dabigatran etexilate)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">active bleeding; impaired haemostasis</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">avoid in severe liver disease, especially if prothrombin time already prolonged</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">for <em>prophylaxis of venous thromboembolism following knee or hip replacement surgery</em>, reduce initial dose to 75 mg and subsequent doses to 150 mg once daily if eGFR 30–50 mL/minute/1.73 m<sup>2</sup>; reduce dose to 75 mg once daily if eGFR 30–50 mL/minute/1.73 m<sup>2</sup> and patient receiving concomitant treatment with verapamil; avoid if eGFR less than 30 mL/minute/1.73 m<sup>2</sup>; for <em>prophylaxis of stroke and systemic embolism</em> in atrial fibrillation, avoid if eGFR less than 30 mL/minute/1.73 m<sup>2</sup>; monitor renal function at least annually</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">manufacturer advises avoid unless essential—toxicity in <em>animal</em> studies</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">manufacturer advises avoid—no information available</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">nausea, dyspepsia, diarrhoea, abdominal pain, anaemia, haemorrhage—see <a title="BNF:monograph-family: Dabigatran etexilate" href="PHP1503-dabigatran-etexilate.htm">notes above</a>; <em>less commonly</em> hepatobiliary disorders, vomiting, dysphagia, gastro-intestinal ulcer, gastro-oesophageal reflux, oesophagitis, thrombocytopenia</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>Prophylaxis of venous thromboembolism following total knee replacement surgery, <span class="cP">adult</span> over 18 years, 110 mg (<span class="cP">elderly</span> over 75 years, 75 mg) 1–4 hours after surgery, <em>then</em> 220 mg (<span class="cP">elderly</span> over 75 years or patient receiving concomitant treatment with amiodarone or verapamil, 150 mg) once daily for 9 days</p></li> <li><p>Prophylaxis of venous thromboembolism following total hip replacement surgery, <span class="cP">adult</span> over 18 years, 110 mg (<span class="cP">elderly</span> over 75 years, 75 mg) 1–4 hours after surgery, <em>then</em> 220 mg (<span class="cP">elderly</span> over 75 years or patient receiving concomitant treatment with amiodarone or verapamil, 150 mg) once daily for 27–34 days</p></li> <li><p>Prophylaxis of stroke and systemic embolism in non-valvular atrial fibrillation (see <a title="BNF:monograph-family: Dabigatran etexilate" href="PHP1503-dabigatran-etexilate.htm">notes above</a>), <span class="cP">adult</span> over 18 years, 150 mg (<span class="cP">elderly</span> over 80 years, patients at high risk of bleeding, or receiving concomitant treatment with verapamil, 110 mg) twice daily</p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="PHP1506-pradaxa.htm#PHP1506-pradaxa" title="Pradaxa®">Pradaxa®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP1503-dabigatran-etexilate.htm">Previous: Dabigatran etexilate</a> | <a class="top" href="PHP1505-dabigatran-etexilate.htm#">Top</a> | <a accesskey="]" href="PHP1506-pradaxa.htm#PHP1506-pradaxa" title="Pradaxa®">Next: Pradaxa®</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>